JPS6327023B2 - - Google Patents
Info
- Publication number
- JPS6327023B2 JPS6327023B2 JP55050735A JP5073580A JPS6327023B2 JP S6327023 B2 JPS6327023 B2 JP S6327023B2 JP 55050735 A JP55050735 A JP 55050735A JP 5073580 A JP5073580 A JP 5073580A JP S6327023 B2 JPS6327023 B2 JP S6327023B2
- Authority
- JP
- Japan
- Prior art keywords
- membrane module
- plasma
- blood
- molecular weight
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000012528 membrane Substances 0.000 claims description 92
- 210000004369 blood Anatomy 0.000 claims description 29
- 239000008280 blood Substances 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 26
- 210000000601 blood cell Anatomy 0.000 claims description 19
- 238000009795 derivation Methods 0.000 claims description 8
- 230000004087 circulation Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 description 43
- 239000000306 component Substances 0.000 description 24
- 238000000926 separation method Methods 0.000 description 9
- 239000012530 fluid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000012510 hollow fiber Substances 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 4
- 108010074605 gamma-Globulins Proteins 0.000 description 4
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002637 fluid replacement therapy Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5073580A JPS56145859A (en) | 1980-04-16 | 1980-04-16 | Treating device for blood |
US06/252,245 US4350594A (en) | 1980-04-16 | 1981-04-08 | Blood purification using plural ultrafiltration stages |
DE8181301613T DE3171458D1 (en) | 1980-04-16 | 1981-04-13 | Blood treatment apparatus |
EP81301613A EP0038203B1 (en) | 1980-04-16 | 1981-04-13 | Blood treatment apparatus |
CA000375402A CA1151044A (en) | 1980-04-16 | 1981-04-14 | Blood treatment apparatus and method of treating blood |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5073580A JPS56145859A (en) | 1980-04-16 | 1980-04-16 | Treating device for blood |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56145859A JPS56145859A (en) | 1981-11-12 |
JPS6327023B2 true JPS6327023B2 (ko) | 1988-06-01 |
Family
ID=12867097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5073580A Granted JPS56145859A (en) | 1980-04-16 | 1980-04-16 | Treating device for blood |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56145859A (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5878668A (ja) * | 1981-11-04 | 1983-05-12 | 株式会社クラレ | 血液の処理装置 |
JPS58206758A (ja) * | 1982-05-28 | 1983-12-02 | 株式会社クラレ | 血漿分離装置 |
JPS6173669A (ja) * | 1984-09-20 | 1986-04-15 | 旭メデイカル株式会社 | 血漿浄化装置 |
US4708713A (en) * | 1984-11-16 | 1987-11-24 | Anisa Medical, Inc. | Method and system for removing immunosuppressive components from the blood of mammals |
-
1980
- 1980-04-16 JP JP5073580A patent/JPS56145859A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS56145859A (en) | 1981-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0038203B1 (en) | Blood treatment apparatus | |
US4397747A (en) | Apparatus for plasma separation/exchange by double filtration | |
US4747952A (en) | Method and apparatus for plasma treatment | |
US4839055A (en) | Method for treating blood and apparatus therefor | |
JPH08295630A (ja) | 血漿分離方法 | |
JPS6327023B2 (ko) | ||
US4832839A (en) | Hemopurification apparatus | |
JPS6327024B2 (ko) | ||
US7632474B2 (en) | Device, cartridge and method for solving powder in liquid, when manufacturing a dialysis fluid | |
JPH019575Y2 (ko) | ||
JPS6040303B2 (ja) | 二重ロ過型血漿分離交換装置 | |
JPS60256465A (ja) | 血液の処理装置 | |
JPH059008Y2 (ko) | ||
JPH01104272A (ja) | 血液の処理装置 | |
JPS6040302B2 (ja) | 二重ロ過型血漿分離交換装置 | |
Sanz‐Moreno et al. | Hemodiafiltration in two chambers without replacement fluid: a clinical study | |
JPH0244759Y2 (ko) | ||
JPS64940Y2 (ko) | ||
Nosé et al. | Plasma filtration detoxification on hepatic patients: its optimal operating conditions | |
JPS60179065A (ja) | 血液処理装置 | |
JPH043985B2 (ko) | ||
JPS6124019B2 (ko) | ||
JPS6099263A (ja) | 血液処理装置 | |
JPH0225407Y2 (ko) | ||
JPS609821B2 (ja) | 血液浄化装置 |